首页 > 最新文献

Cardiovascular diagnosis and therapy最新文献

英文 中文
The Cleveland Clinic experience of eosinophilic myocarditis in the setting of hypereosinophilic syndrome: demographics, cardiac imaging, and outcomes. 克利夫兰诊所嗜酸性粒细胞性心肌炎在嗜酸性粒细胞增多综合征的背景下的经验:人口统计学,心脏成像和结果。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-02 DOI: 10.21037/cdt-24-347
Matthew Reeder, Yuichiro Okushi, Saberio Lo Presti Vega, Rohan Prasad, Richard A Grimm, Brian P Griffin, Bo Xu

Background: Hypereosinophilic syndrome (HES) represents a group of disorders with eosinophil-mediated end-organ damage. Eosinophilic myocarditis (EM) represents cardiac involvement in HES. Data are limited regarding this rare condition. To better understand contemporary clinical characteristics of EM in HES, we reviewed demographics, cardiac imaging, and outcomes of this condition at our center.

Methods: We performed a cross-sectional study of all patients aged >18 years with diagnosis of EM in HES at our center between September 1986 and January 2023. Relevant clinical data, including clinical presentation, medical history, medication use, comorbidities, imaging findings, and outcomes, were collected and analyzed.

Results: Of 1,664 patients identified with hypereosinophilia (HE), 36 cases of clinically diagnosed HES were identified. Of the 36 patients diagnosed with HES, 11 patients (30.6%) were diagnosed with EM. Of these, six patients underwent endomyocardial biopsy (EMB). The mean age was 57±12 years and 63.6% were female. Asthma was the most common comorbidity (54.5%). Patients with EM had significantly more dyspnea (63.6%), fatigue (54.5%), and neuropathy (36.4%) compared to those without cardiac involvement. Echocardiography was performed in all patients and cardiac magnetic resonance (CMR) imaging was performed in eight patients. Left ventricular (LV) thrombus was detected more frequently by CMR (5/8, 62.5%) compared to echocardiography (3/10, 30%). Subendocardial pattern of late gadolinium enhancement (LGE) was observed in the majority of patients on CMR (6/7, 85.7%). Steroids were utilized in 90.9% of cases, and aspirin in all patients. Compared to HES patients without cardiac involvement, thromboembolic events occurred significantly more frequently (63.6% vs. 24.0%, P=0.02).

Conclusions: In a 37-year cohort of HES-associated EM, echocardiography was the first-line imaging modality, while CMR was an essential but still under-utilized imaging modality. Patients with EM had significantly more thromboembolic events compared to HES without cardiac involvement.

背景:高嗜酸性粒细胞综合征(HES)是一组由嗜酸性粒细胞介导的终末器官损伤引起的疾病。嗜酸性心肌炎(EM)代表HES累及心脏。关于这种罕见疾病的资料有限。为了更好地了解HES中EM的当代临床特征,我们回顾了人口统计学、心脏影像学和本中心这种情况的结果。方法:我们对1986年9月至2023年1月期间在我们中心的所有年龄在bb0 - 18岁之间诊断为EM的HES患者进行了横断面研究。收集并分析相关临床资料,包括临床表现、病史、用药、合并症、影像学表现和结局。结果:1664例确诊为嗜酸性粒细胞增多症(HE)的患者中,有36例临床诊断为HE。在诊断为HES的36例患者中,有11例(30.6%)被诊断为EM。其中6例患者接受了心内膜心肌活检(EMB)。平均年龄57±12岁,女性占63.6%。哮喘是最常见的合并症(54.5%)。与没有心脏受累的患者相比,EM患者明显有更多的呼吸困难(63.6%)、疲劳(54.5%)和神经病变(36.4%)。所有患者均行超声心动图检查,8例患者行心脏磁共振(CMR)检查。CMR检测左心室血栓的频率(5/ 8,62.5%)高于超声心动图(3/ 10,30%)。大多数CMR患者均观察到心内膜下晚期钆增强(LGE)模式(6/7,85.7%)。90.9%的患者使用类固醇,所有患者使用阿司匹林。与没有心脏受累的HES患者相比,血栓栓塞事件的发生率明显更高(63.6%比24.0%,P=0.02)。结论:在37年的hes相关EM队列中,超声心动图是一线成像方式,而CMR是必不可少但仍未充分利用的成像方式。与没有心脏受累的HES相比,EM患者有明显更多的血栓栓塞事件。
{"title":"The Cleveland Clinic experience of eosinophilic myocarditis in the setting of hypereosinophilic syndrome: demographics, cardiac imaging, and outcomes.","authors":"Matthew Reeder, Yuichiro Okushi, Saberio Lo Presti Vega, Rohan Prasad, Richard A Grimm, Brian P Griffin, Bo Xu","doi":"10.21037/cdt-24-347","DOIUrl":"10.21037/cdt-24-347","url":null,"abstract":"<p><strong>Background: </strong>Hypereosinophilic syndrome (HES) represents a group of disorders with eosinophil-mediated end-organ damage. Eosinophilic myocarditis (EM) represents cardiac involvement in HES. Data are limited regarding this rare condition. To better understand contemporary clinical characteristics of EM in HES, we reviewed demographics, cardiac imaging, and outcomes of this condition at our center.</p><p><strong>Methods: </strong>We performed a cross-sectional study of all patients aged >18 years with diagnosis of EM in HES at our center between September 1986 and January 2023. Relevant clinical data, including clinical presentation, medical history, medication use, comorbidities, imaging findings, and outcomes, were collected and analyzed.</p><p><strong>Results: </strong>Of 1,664 patients identified with hypereosinophilia (HE), 36 cases of clinically diagnosed HES were identified. Of the 36 patients diagnosed with HES, 11 patients (30.6%) were diagnosed with EM. Of these, six patients underwent endomyocardial biopsy (EMB). The mean age was 57±12 years and 63.6% were female. Asthma was the most common comorbidity (54.5%). Patients with EM had significantly more dyspnea (63.6%), fatigue (54.5%), and neuropathy (36.4%) compared to those without cardiac involvement. Echocardiography was performed in all patients and cardiac magnetic resonance (CMR) imaging was performed in eight patients. Left ventricular (LV) thrombus was detected more frequently by CMR (5/8, 62.5%) compared to echocardiography (3/10, 30%). Subendocardial pattern of late gadolinium enhancement (LGE) was observed in the majority of patients on CMR (6/7, 85.7%). Steroids were utilized in 90.9% of cases, and aspirin in all patients. Compared to HES patients without cardiac involvement, thromboembolic events occurred significantly more frequently (63.6% <i>vs.</i> 24.0%, P=0.02).</p><p><strong>Conclusions: </strong>In a 37-year cohort of HES-associated EM, echocardiography was the first-line imaging modality, while CMR was an essential but still under-utilized imaging modality. Patients with EM had significantly more thromboembolic events compared to HES without cardiac involvement.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1122-1133"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortopathy in repaired tetralogy of Fallot and David procedure. 法洛四联症修复中的主动脉病变。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-10-31 DOI: 10.21037/cdt-24-264
Naoko Ichikawa, Yumi Shiina, Kohei Abe, Koichiro Niwa

Tetralogy of Fallot (TOF) is a condition that often leads to long-term enlargement of the aortic root in after surgery. The aortic dilation is believed to be caused by histological abnormalities of the aortic media and the hemodynamic characteristics of increased aortic flow, compared to pulmonary flow. Severe cyanosis, severe right ventricular outflow tract (RVOT) obstruction, older age at repair, a larger aortic size at the time of repair, and a history of an aortopulmonary shunt parameters related to long-standing volume overload of the aortic root were the reported risk factors. Right aortic arch, male sex, and the association of chromosome 22q11 deletion were also reported to be risk factors. The enlargement of the aortic root can cause aortic regurgitation (AR), leading to left ventricular dysfunction and an increased risk of aortic dissection, necessitating surgical intervention. The outcomes of aortic valve repair for AR have improved, leading to an increasing trend of choosing this approach, particularly in younger patients who would otherwise require mechanical valve replacement, thereby avoiding the need for anticoagulation therapy. The indications and timing of prophylactic aortic root replacement in adult patients with congenital heart disease have not been described, and the current consensus recommends surgical intervention for an ascending aorta with a diameter of ≥55 mm. In this review article, we focus on valve-sparing root replacement (VSRR) in TOF.

法洛四联症(TOF)是一种经常导致术后主动脉根部长期扩大的疾病。与肺血流相比,主动脉扩张被认为是由主动脉介质的组织学异常和主动脉血流增加的血流动力学特征引起的。严重紫绀、严重右心室流出道(RVOT)梗阻、修复时年龄较大、修复时主动脉尺寸较大以及与主动脉根部长期容量过载相关的主动脉-肺分流术史是报道的危险因素。右主动脉弓、男性和22q11染色体缺失也被报道为危险因素。主动脉根部扩大可引起主动脉反流(AR),导致左心室功能障碍和主动脉夹层风险增加,需要手术干预。主动脉瓣修复治疗AR的结果有所改善,导致选择这种方法的趋势增加,特别是在需要机械瓣膜置换术的年轻患者中,从而避免了抗凝治疗的需要。成人先天性心脏病患者预防性主动脉根置换术的适应症和时机尚未描述,目前的共识是对升主动脉直径≥55mm的患者进行手术干预。在这篇综述文章中,我们着重于保留瓣膜的根置换(VSRR)在TOF中的应用。
{"title":"Aortopathy in repaired tetralogy of Fallot and David procedure.","authors":"Naoko Ichikawa, Yumi Shiina, Kohei Abe, Koichiro Niwa","doi":"10.21037/cdt-24-264","DOIUrl":"10.21037/cdt-24-264","url":null,"abstract":"<p><p>Tetralogy of Fallot (TOF) is a condition that often leads to long-term enlargement of the aortic root in after surgery. The aortic dilation is believed to be caused by histological abnormalities of the aortic media and the hemodynamic characteristics of increased aortic flow, compared to pulmonary flow. Severe cyanosis, severe right ventricular outflow tract (RVOT) obstruction, older age at repair, a larger aortic size at the time of repair, and a history of an aortopulmonary shunt parameters related to long-standing volume overload of the aortic root were the reported risk factors. Right aortic arch, male sex, and the association of chromosome 22q11 deletion were also reported to be risk factors. The enlargement of the aortic root can cause aortic regurgitation (AR), leading to left ventricular dysfunction and an increased risk of aortic dissection, necessitating surgical intervention. The outcomes of aortic valve repair for AR have improved, leading to an increasing trend of choosing this approach, particularly in younger patients who would otherwise require mechanical valve replacement, thereby avoiding the need for anticoagulation therapy. The indications and timing of prophylactic aortic root replacement in adult patients with congenital heart disease have not been described, and the current consensus recommends surgical intervention for an ascending aorta with a diameter of ≥55 mm. In this review article, we focus on valve-sparing root replacement (VSRR) in TOF.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1228-1235"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Greater than the sum of its parts: multimodality imaging in adults with congenital heart disease. 大于其各部分之和:成人先天性心脏病的多模态成像。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-19 DOI: 10.21037/cdt-24-363
Nicholas Szugye

As the population of adults with congenital heart disease (ACHD) grows, there also grows an expanded need for non-invasive surveillance methods to guide management and intervention. A multimodal imaging approach layers complementary insights from echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and other modalities into a clinician's view of patient physiology. Merely applying strategies from acquired adult cardiac disease would be inadequate and potentially misleading. As data amasses in this small but growing population, investigators in the field of ACHD have discovered population-specific imaging biomarkers that identify deterioration and pivotal time points where intervention may reduce morbidity and mortality. Moreover, due to the variety of physiologies and the modest number of ACHD patients relative to that of adults with acquired heart disease, multicenter registries will be key in advancing research. The integration of well-defined imaging variables into these databases can help identify important biomarkers. Emerging technologies like computational fluid dynamics (CFD) and artificial intelligence (AI) are also primed to enhance imaging capabilities and clinical workflows, though require careful adaption as ACHD patients are not meaningfully represented in the training data for these technologies. Ultimately, a multimodal imaging approach is essential for optimizing care for ACHD patients, enabling personalized medicine where interventions can be performed before clinical deterioration occurs.

随着患有先天性心脏病(ACHD)的成人人数的增加,对非侵入性监测方法的需求也在扩大,以指导管理和干预。多模式成像方法将超声心动图、计算机断层扫描(CT)、磁共振成像(MRI)和其他模式的互补见解分层,纳入临床医生对患者生理学的看法。仅仅应用获得性成人心脏病的策略是不充分的,并且可能具有误导性。随着数据在这个小而不断增长的人群中积累,ACHD领域的研究人员已经发现了特定人群的成像生物标志物,可以识别恶化和关键时间点,干预可以降低发病率和死亡率。此外,由于ACHD患者的生理变化多样,而且与成人获得性心脏病患者相比,ACHD患者的数量较少,因此多中心登记将是推进研究的关键。将定义良好的成像变量整合到这些数据库中可以帮助识别重要的生物标志物。计算流体动力学(CFD)和人工智能(AI)等新兴技术也有望增强成像能力和临床工作流程,但需要仔细调整,因为这些技术的培训数据中并没有有意义的代表ACHD患者。最终,多模态成像方法对于优化ACHD患者的护理至关重要,可以在临床恶化发生之前进行个性化医疗干预。
{"title":"Greater than the sum of its parts: multimodality imaging in adults with congenital heart disease.","authors":"Nicholas Szugye","doi":"10.21037/cdt-24-363","DOIUrl":"10.21037/cdt-24-363","url":null,"abstract":"<p><p>As the population of adults with congenital heart disease (ACHD) grows, there also grows an expanded need for non-invasive surveillance methods to guide management and intervention. A multimodal imaging approach layers complementary insights from echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and other modalities into a clinician's view of patient physiology. Merely applying strategies from acquired adult cardiac disease would be inadequate and potentially misleading. As data amasses in this small but growing population, investigators in the field of ACHD have discovered population-specific imaging biomarkers that identify deterioration and pivotal time points where intervention may reduce morbidity and mortality. Moreover, due to the variety of physiologies and the modest number of ACHD patients relative to that of adults with acquired heart disease, multicenter registries will be key in advancing research. The integration of well-defined imaging variables into these databases can help identify important biomarkers. Emerging technologies like computational fluid dynamics (CFD) and artificial intelligence (AI) are also primed to enhance imaging capabilities and clinical workflows, though require careful adaption as ACHD patients are not meaningfully represented in the training data for these technologies. Ultimately, a multimodal imaging approach is essential for optimizing care for ACHD patients, enabling personalized medicine where interventions can be performed before clinical deterioration occurs.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1176-1185"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical diagnostic value of right-to-left shunt in cryptogenic stroke under right heart contrast echocardiography: a retrospective case-control study. 右心超声造影右向左分流对隐源性脑卒中的临床诊断价值:回顾性病例对照研究。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-19 DOI: 10.21037/cdt-24-288
Changyin Gao, Yanjie Liu, Dong Xu

Background: About 30% of ischemic strokes do not have a clear cause, which is called cryptogenic stroke (CS). Increasing evidence suggests a potential link between CS and right-to-left shunt (RLS). RLS may lead to CS via paradoxical embolic mechanism. Hence, current study aims to explore the correlation between different RLS indexes and the occurrence of CS and its clinical diagnostic value in CS.

Methods: A total of 117 patients diagnosed with CS from October 2020 to June 2024 were randomly collected, and 93 patients with only headache and dizziness were randomly collected as the control group. All patients underwent agitated saline contrast echocardiography (ASCE) and the semi-quantitative classification, type and duration of RLS were analyzed. Spearman correlation analysis was used to analyze the correlation between RLS grade and type and the occurrence of CS, and the correlation between RLS duration and RLS grade and type. The efficacy of different RLS grades, types and durations in the diagnosis of CS were analyzed by receiver operating characteristic (ROC) curve.

Results: The included population ranged in age from 20-73 years, with 90 males and 120 females. There was no significant difference in basic data (e.g., gender, smoking history, drinking history, and the number of people with hypertension and diabetes) and serum biological indicators [triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL)] between the CS group and the control group (all P>0.05). The proportion of RLS (77.78%) in the CS group was significantly higher than that in the control group (35.48%) (P<0.001). Spearman correlation analysis showed that RLS grade (r=0.569) and type (r=0.346) were significantly correlated with the occurrence of CS (both P<0.001). In addition, RLS duration was significantly correlated with RLS type (r=0.902, P<0.001), but not with RLS size (P>0.05). ROC curve analysis showed that RLS grade had the highest area under the curve (AUC) in CS diagnosis, which was 0.807 [95% confidence interval (CI): 0.748-0.866], the diagnostic sensitivity was 68.4%, and the specificity was 87.1%. In addition, the diagnostic AUC of RLS type and RLS duration in CS were similar, at 0.700 (95% CI: 0.626-0.773) and 0.707 (95% CI: 0.634-0.780), respectively.

Conclusions: RLS grade and RLS type are significantly correlated with the occurrence of CS. As an auxiliary means of CS diagnosis, RLS grade can effectively reduce the misdiagnosis rate of CS, which is of great clinical significance for early detection of CS risk.

背景:约30%的缺血性卒中病因不明,称为隐源性卒中(cryptogenic stroke, CS)。越来越多的证据表明,CS与右至左分流(RLS)之间存在潜在联系。RLS可能通过矛盾的栓塞机制导致CS。因此,本研究旨在探讨不同RLS指标与CS发生的相关性及其在CS中的临床诊断价值。方法:随机收集2020年10月至2024年6月诊断为CS的患者117例,其中仅头痛、头晕的患者93例作为对照组。所有患者均行激动生理盐水对比超声心动图(ASCE),分析RLS的半定量分类、类型和持续时间。采用Spearman相关分析分析RLS分级、类型与CS发生的相关性,RLS持续时间与RLS分级、类型的相关性。采用受试者工作特征(ROC)曲线分析不同RLS分级、类型及持续时间对CS的诊断效果。结果:纳入人群年龄20 ~ 73岁,男性90例,女性120例。CS组与对照组在基本资料(如性别、吸烟史、饮酒史、高血压合并糖尿病人数)和血清生物学指标(甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL))方面差异均无统计学意义(P < 0.05)。CS组RLS发生率(77.78%)显著高于对照组(35.48%)(P0.05)。ROC曲线分析显示,RLS分级在CS诊断中的曲线下面积(AUC)最高,为0.807[95%可信区间(CI): 0.748 ~ 0.866],诊断敏感性为68.4%,特异性为87.1%。此外,CS的RLS类型和RLS持续时间的诊断AUC相似,分别为0.700 (95% CI: 0.626-0.773)和0.707 (95% CI: 0.634-0.780)。结论:RLS分级、RLS类型与CS的发生有显著相关性。RLS分级作为CS诊断的辅助手段,可有效降低CS的误诊率,对早期发现CS风险具有重要的临床意义。
{"title":"The clinical diagnostic value of right-to-left shunt in cryptogenic stroke under right heart contrast echocardiography: a retrospective case-control study.","authors":"Changyin Gao, Yanjie Liu, Dong Xu","doi":"10.21037/cdt-24-288","DOIUrl":"10.21037/cdt-24-288","url":null,"abstract":"<p><strong>Background: </strong>About 30% of ischemic strokes do not have a clear cause, which is called cryptogenic stroke (CS). Increasing evidence suggests a potential link between CS and right-to-left shunt (RLS). RLS may lead to CS via paradoxical embolic mechanism. Hence, current study aims to explore the correlation between different RLS indexes and the occurrence of CS and its clinical diagnostic value in CS.</p><p><strong>Methods: </strong>A total of 117 patients diagnosed with CS from October 2020 to June 2024 were randomly collected, and 93 patients with only headache and dizziness were randomly collected as the control group. All patients underwent agitated saline contrast echocardiography (ASCE) and the semi-quantitative classification, type and duration of RLS were analyzed. Spearman correlation analysis was used to analyze the correlation between RLS grade and type and the occurrence of CS, and the correlation between RLS duration and RLS grade and type. The efficacy of different RLS grades, types and durations in the diagnosis of CS were analyzed by receiver operating characteristic (ROC) curve.</p><p><strong>Results: </strong>The included population ranged in age from 20-73 years, with 90 males and 120 females. There was no significant difference in basic data (e.g., gender, smoking history, drinking history, and the number of people with hypertension and diabetes) and serum biological indicators [triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL)] between the CS group and the control group (all P>0.05). The proportion of RLS (77.78%) in the CS group was significantly higher than that in the control group (35.48%) (P<0.001). Spearman correlation analysis showed that RLS grade (r=0.569) and type (r=0.346) were significantly correlated with the occurrence of CS (both P<0.001). In addition, RLS duration was significantly correlated with RLS type (r=0.902, P<0.001), but not with RLS size (P>0.05). ROC curve analysis showed that RLS grade had the highest area under the curve (AUC) in CS diagnosis, which was 0.807 [95% confidence interval (CI): 0.748-0.866], the diagnostic sensitivity was 68.4%, and the specificity was 87.1%. In addition, the diagnostic AUC of RLS type and RLS duration in CS were similar, at 0.700 (95% CI: 0.626-0.773) and 0.707 (95% CI: 0.634-0.780), respectively.</p><p><strong>Conclusions: </strong>RLS grade and RLS type are significantly correlated with the occurrence of CS. As an auxiliary means of CS diagnosis, RLS grade can effectively reduce the misdiagnosis rate of CS, which is of great clinical significance for early detection of CS risk.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1048-1057"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early and late outcomes after Cardioband procedure in patients with atrial and non-atrial functional tricuspid regurgitation. 心房和非心房功能性三尖瓣反流患者心脏带手术后的早期和晚期结局。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-17 DOI: 10.21037/cdt-24-407
Piera Ciaramella, Francesco Candido, Marco Russo, Antonio Giovanni Cammardella, Amedeo Pergolini, Federico Ranocchi
{"title":"Early and late outcomes after Cardioband procedure in patients with atrial and non-atrial functional tricuspid regurgitation.","authors":"Piera Ciaramella, Francesco Candido, Marco Russo, Antonio Giovanni Cammardella, Amedeo Pergolini, Federico Ranocchi","doi":"10.21037/cdt-24-407","DOIUrl":"10.21037/cdt-24-407","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"991-993"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of myocardial perfusion imaging techniques and artificial intelligence (AI) tools in coronary artery disease (CAD) diagnosis through multi-criteria decision-making method. 通过多准则决策方法评价心肌灌注成像技术和人工智能(AI)工具在冠状动脉疾病(CAD)诊断中的应用
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-09 DOI: 10.21037/cdt-24-237
Hasan Erdagli, Dilber Uzun Ozsahin, Berna Uzun

Background: Cardiovascular diseases (CVDs) continue to be the world's greatest cause of death. To evaluate heart function and diagnose coronary artery disease (CAD), myocardial perfusion imaging (MPI) has become essential. Artificial intelligence (AI) methods have been incorporated into diagnostic methods such as MPI to improve patient outcomes in recent years. This study aims to employ a novel approach to examine how parameters/criteria and performance metrics affect the prioritization of selected MPI techniques and AI tools in CAD diagnosis. Identifying the most effective method in these two interconnected areas will increase the CAD diagnosis rate.

Methods: The study includes an in-depth investigation of popular convolutional neural network (CNN) models, including InceptionV3, VGG16, ResNet50, and DenseNet121, in addition to widely used machine learning (ML) models, including random forests (RF), K-nearest neighbor (KNN), support vector machine (SVM), and Naïve Bayes (NB). In addition, it includes the evaluation of nuclear MPI techniques, including positron emission tomography (PET) and single photon emission computed tomography (SPECT), with the non-nuclear MPI technique of cardiovascular magnetic resonance imaging (CMR). Various performance metrics were used to evaluate AI tools. They are F1-score, recall, specificity, precision, accuracy, and area under the receiver operating characteristic curve (AUC-ROC). For MPI techniques, the evaluation criteria include specificity, sensitivity, radiation dose, cost of scan, and study duration. The analysis was evaluated and compared using the fuzzy-based preference ranking organization method for enrichment evaluation (PROMETHEE), the multi-criteria decision-making method (MDCM).

Results: According to the study's findings, considering selected performance metrics or criteria, RF is the most efficient AI tool for SPECT MPI in the diagnosis of CAD with a net flow (Φnet ) of 0.3778, and it's revealed that CMR is the most efficient MPI technique for CAD diagnosis with a net flow of 0.3666. By expanding this study, more comprehensive evaluations can be made in the diagnosis of CAD.

Conclusions: It was concluded that CMR outperformed the nuclear MPI techniques. SPECT, as the least advantageous technique, remained below average on other criteria except for the cost of the scan. Integrating the RF algorithm, which stands out as the most effective AI tool in diagnosing CAD, with SPECT MPI may contribute to SPECT becoming a superior alternative.

背景:心血管疾病(cvd)仍然是世界上最大的死因。为了评估心功能和诊断冠状动脉疾病(CAD),心肌灌注成像(MPI)已变得必不可少。近年来,人工智能(AI)方法已被纳入MPI等诊断方法,以改善患者的治疗效果。本研究旨在采用一种新颖的方法来研究参数/标准和性能指标如何影响CAD诊断中所选MPI技术和人工智能工具的优先级。在这两个相互关联的领域中确定最有效的方法将提高CAD诊断率。方法:该研究包括深入研究流行的卷积神经网络(CNN)模型,包括InceptionV3、VGG16、ResNet50和DenseNet121,以及广泛使用的机器学习(ML)模型,包括随机森林(RF)、k近邻(KNN)、支持向量机(SVM)和Naïve贝叶斯(NB)。此外,它还包括核MPI技术的评估,包括正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT),与心血管磁共振成像(CMR)的非核MPI技术。使用各种性能指标来评估人工智能工具。它们是f1评分、召回率、特异性、精密度、准确度和受试者工作特征曲线下面积(AUC-ROC)。对于MPI技术,评估标准包括特异性、敏感性、辐射剂量、扫描成本和研究持续时间。采用基于模糊的富集评价偏好排序组织法(PROMETHEE)和多准则决策法(MDCM)对分析结果进行评价和比较。结果:根据研究结果,考虑选定的性能指标或标准,RF是SPECT MPI诊断CAD最有效的人工智能工具,净流量(Φnet)为0.3778,CMR是最有效的MPI技术,净流量为0.3666。通过扩大本研究,可以对CAD的诊断做出更全面的评价。结论:CMR技术优于核MPI技术。SPECT作为最不有利的技术,除了扫描成本外,在其他标准上仍低于平均水平。将射频算法作为CAD诊断中最有效的人工智能工具与SPECT MPI相结合,可能有助于SPECT成为一种更好的选择。
{"title":"Evaluation of myocardial perfusion imaging techniques and artificial intelligence (AI) tools in coronary artery disease (CAD) diagnosis through multi-criteria decision-making method.","authors":"Hasan Erdagli, Dilber Uzun Ozsahin, Berna Uzun","doi":"10.21037/cdt-24-237","DOIUrl":"10.21037/cdt-24-237","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) continue to be the world's greatest cause of death. To evaluate heart function and diagnose coronary artery disease (CAD), myocardial perfusion imaging (MPI) has become essential. Artificial intelligence (AI) methods have been incorporated into diagnostic methods such as MPI to improve patient outcomes in recent years. This study aims to employ a novel approach to examine how parameters/criteria and performance metrics affect the prioritization of selected MPI techniques and AI tools in CAD diagnosis. Identifying the most effective method in these two interconnected areas will increase the CAD diagnosis rate.</p><p><strong>Methods: </strong>The study includes an in-depth investigation of popular convolutional neural network (CNN) models, including InceptionV3, VGG16, ResNet50, and DenseNet121, in addition to widely used machine learning (ML) models, including random forests (RF), K-nearest neighbor (KNN), support vector machine (SVM), and Naïve Bayes (NB). In addition, it includes the evaluation of nuclear MPI techniques, including positron emission tomography (PET) and single photon emission computed tomography (SPECT), with the non-nuclear MPI technique of cardiovascular magnetic resonance imaging (CMR). Various performance metrics were used to evaluate AI tools. They are F1-score, recall, specificity, precision, accuracy, and area under the receiver operating characteristic curve (AUC-ROC). For MPI techniques, the evaluation criteria include specificity, sensitivity, radiation dose, cost of scan, and study duration. The analysis was evaluated and compared using the fuzzy-based preference ranking organization method for enrichment evaluation (PROMETHEE), the multi-criteria decision-making method (MDCM).</p><p><strong>Results: </strong>According to the study's findings, considering selected performance metrics or criteria, RF is the most efficient AI tool for SPECT MPI in the diagnosis of CAD with a net flow (<i>Φ<sup>net</sup></i> ) of 0.3778, and it's revealed that CMR is the most efficient MPI technique for CAD diagnosis with a net flow of 0.3666. By expanding this study, more comprehensive evaluations can be made in the diagnosis of CAD.</p><p><strong>Conclusions: </strong>It was concluded that CMR outperformed the nuclear MPI techniques. SPECT, as the least advantageous technique, remained below average on other criteria except for the cost of the scan. Integrating the RF algorithm, which stands out as the most effective AI tool in diagnosing CAD, with SPECT MPI may contribute to SPECT becoming a superior alternative.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1134-1147"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Let us pay more attention to performing coronary function assessment for multivessels! 让我们更加重视多血管冠状动脉功能的评估!
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-19 DOI: 10.21037/cdt-24-454
Hiroki Teragawa, Chikage Oshita, Yu Hashimoto
{"title":"Let us pay more attention to performing coronary function assessment for multivessels!","authors":"Hiroki Teragawa, Chikage Oshita, Yu Hashimoto","doi":"10.21037/cdt-24-454","DOIUrl":"10.21037/cdt-24-454","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"998-1002"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged pre-catheterization fasting: do the risks outweigh the benefits? 导尿前长时间禁食:弊大于利吗?
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-18 DOI: 10.21037/cdt-24-395
Anand Shah, George A Stouffer
{"title":"Prolonged pre-catheterization fasting: do the risks outweigh the benefits?","authors":"Anand Shah, George A Stouffer","doi":"10.21037/cdt-24-395","DOIUrl":"10.21037/cdt-24-395","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1020-1024"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of sodium-glucose cotransporter 2 inhibitors on the triglyceride-glucose index in acute myocardial infarction patients with type 2 diabetes mellitus. 钠-葡萄糖共转运蛋白2抑制剂对2型糖尿病急性心肌梗死患者甘油三酯-葡萄糖指数的影响
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-11 DOI: 10.21037/cdt-24-287
Kai Wang, Tingting Fan, Fei He, Haoliang Li, Yu Fang, Guangquan Hu, Xiaochen Wang
<p><strong>Background: </strong>As a novel oral anti-hyperglycemic agent, sodium-glucose cotransporter 2 inhibitors (SGLT2-i) have been demonstrated to improve cardiovascular outcomes in acute myocardial infarction (AMI) patients with type 2 diabetes mellitus (T2DM). However, the mechanism responsible for the beneficial effects remains unclear. Recently, extensive studies have demonstrated a close relationship between elevated fasting triglyceride-glucose (TyG) index and the risk of AMI. Additionally, research has identified that SGLT2-i can reduce the TyG index in T2DM patients. However, it remains ambiguous whether the benefit of SGLT2-i in patients with AMI and T2DM is due to an improvement in the TyG index. Consequently, we aimed to assess the impact of SGLT2-i on the TyG index in AMI patients with T2DM.</p><p><strong>Methods: </strong>A retrospective and cross-sectional study was conducted on 180 AMI patients with T2DM admitted to the chest pain center of the Second Affiliated Hospital of Anhui Medical University from January 2020 to January 2023. Based on the hypoglycemic regimens administered after admission, the patients were categorized into a control group (79 cases treated with sulfonylureas, α-glycosidase inhibitors, metformin, etc.) and a SGLT2-i group (101 cases administered with dapagliflozin or empagliflozin). Propensity score matching (PSM) was adopted to balance the baseline characteristics of patients and minimize selection bias to confirm the robustness of the results. After PSM, control group remained 32 patients, and SGLT2-i group remained 37 patients. All patients underwent regular follow-up after discharge, and comparisons were made between the two groups in terms of clinical indicators and major adverse cardiovascular events (MACEs) in 1 year. Univariate and Multivariate Cox regression analysis was performed to identify the predictors of MACE.</p><p><strong>Results: </strong>Significant differences were observed between the two groups in terms of various parameters before PSM, included age, proportion of insulin use, Gensini score, serum creatinine (Cr), total cholesterol (TC), and cardiac troponin I (cTnI). After PSM, there were no statistically significant differences in baseline clinical indicators and laboratory tests. The median follow-up period was 11 months in both cohorts. The comparison of follow-up results between the two groups after matching confirmed statistically significant differences in triglyceride (TG) reduction index reduction, left ventricular end-diastolic diameter (LVDD) reduction, and white blood cell (WBC) reduction in the SGLT2-i group (all P<0.05). Additionally, a higher incidence of MACEs was observed in the control group (P=0.01). Univariate analysis showed that usage of SGLT2-i, Cr, low-density lipoprotein cholesterol (LDL-C), TyG index at baseline, and changes of TyG index (TyG at follow-up minus TyG at baseline) were associated with the risk of MACE. However, multivariate analysis showed on
背景:作为一种新型的口服降糖药,钠-葡萄糖共转运蛋白2抑制剂(SGLT2-i)已被证明可以改善急性心肌梗死(AMI)合并2型糖尿病(T2DM)患者的心血管结局。然而,产生有益效果的机制尚不清楚。近年来,大量研究表明空腹甘油三酯-葡萄糖(TyG)指数升高与AMI风险密切相关。此外,研究发现SGLT2-i可以降低T2DM患者的TyG指数。然而,SGLT2-i对AMI和T2DM患者的益处是否是由于TyG指数的改善,目前尚不清楚。因此,我们旨在评估SGLT2-i对AMI合并T2DM患者TyG指数的影响。方法:对2020年1月至2023年1月安徽医科大学第二附属医院胸痛中心收治的180例AMI合并T2DM患者进行回顾性横断面研究。根据患者入院后的降糖方案,将患者分为对照组(79例使用磺脲类药物、α-糖苷酶抑制剂、二甲双胍等)和SGLT2-i组(101例使用达格列净或恩格列净)。采用倾向评分匹配(PSM)来平衡患者的基线特征,并尽量减少选择偏差,以确认结果的稳健性。经PSM后,对照组32例,SGLT2-i组37例。所有患者出院后均定期随访,比较两组1年内临床指标及主要心血管不良事件(mace)。采用单因素和多因素Cox回归分析确定MACE的预测因素。结果:两组患者PSM前各项指标(年龄、胰岛素使用比例、Gensini评分、血清肌酐(Cr)、总胆固醇(TC)、心肌肌钙蛋白I (cTnI))均有显著差异。经PSM治疗后,两组患者的基线临床指标和实验室检查无统计学差异。两组的中位随访期均为11个月。配对后两组随访结果比较,证实SGLT2-i组在甘油三酯(TG)降低指数、左室舒张末期内径(LVDD)降低、白细胞(WBC)降低方面均有统计学差异(均为p)。结论:在AMI合并T2DM患者中,随访11个月,SGLT2-i的使用与MACE风险降低、TyG指数改善相关。我们的研究结果为SGLT2-i在AMI背景下的心脏保护机制提供了新的见解。
{"title":"Influence of sodium-glucose cotransporter 2 inhibitors on the triglyceride-glucose index in acute myocardial infarction patients with type 2 diabetes mellitus.","authors":"Kai Wang, Tingting Fan, Fei He, Haoliang Li, Yu Fang, Guangquan Hu, Xiaochen Wang","doi":"10.21037/cdt-24-287","DOIUrl":"10.21037/cdt-24-287","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;As a novel oral anti-hyperglycemic agent, sodium-glucose cotransporter 2 inhibitors (SGLT2-i) have been demonstrated to improve cardiovascular outcomes in acute myocardial infarction (AMI) patients with type 2 diabetes mellitus (T2DM). However, the mechanism responsible for the beneficial effects remains unclear. Recently, extensive studies have demonstrated a close relationship between elevated fasting triglyceride-glucose (TyG) index and the risk of AMI. Additionally, research has identified that SGLT2-i can reduce the TyG index in T2DM patients. However, it remains ambiguous whether the benefit of SGLT2-i in patients with AMI and T2DM is due to an improvement in the TyG index. Consequently, we aimed to assess the impact of SGLT2-i on the TyG index in AMI patients with T2DM.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective and cross-sectional study was conducted on 180 AMI patients with T2DM admitted to the chest pain center of the Second Affiliated Hospital of Anhui Medical University from January 2020 to January 2023. Based on the hypoglycemic regimens administered after admission, the patients were categorized into a control group (79 cases treated with sulfonylureas, α-glycosidase inhibitors, metformin, etc.) and a SGLT2-i group (101 cases administered with dapagliflozin or empagliflozin). Propensity score matching (PSM) was adopted to balance the baseline characteristics of patients and minimize selection bias to confirm the robustness of the results. After PSM, control group remained 32 patients, and SGLT2-i group remained 37 patients. All patients underwent regular follow-up after discharge, and comparisons were made between the two groups in terms of clinical indicators and major adverse cardiovascular events (MACEs) in 1 year. Univariate and Multivariate Cox regression analysis was performed to identify the predictors of MACE.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Significant differences were observed between the two groups in terms of various parameters before PSM, included age, proportion of insulin use, Gensini score, serum creatinine (Cr), total cholesterol (TC), and cardiac troponin I (cTnI). After PSM, there were no statistically significant differences in baseline clinical indicators and laboratory tests. The median follow-up period was 11 months in both cohorts. The comparison of follow-up results between the two groups after matching confirmed statistically significant differences in triglyceride (TG) reduction index reduction, left ventricular end-diastolic diameter (LVDD) reduction, and white blood cell (WBC) reduction in the SGLT2-i group (all P&lt;0.05). Additionally, a higher incidence of MACEs was observed in the control group (P=0.01). Univariate analysis showed that usage of SGLT2-i, Cr, low-density lipoprotein cholesterol (LDL-C), TyG index at baseline, and changes of TyG index (TyG at follow-up minus TyG at baseline) were associated with the risk of MACE. However, multivariate analysis showed on","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1096-1107"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning paving the way for successful antegrade crossing of total chronic coronary occlusions. 机器学习为慢性冠状动脉全闭塞成功顺行交叉铺平道路。
IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-31 Epub Date: 2024-12-05 DOI: 10.21037/cdt-24-423
Philipp Breitbart, Dirk Westermann, Grigorios Korosoglou
{"title":"Machine learning paving the way for successful antegrade crossing of total chronic coronary occlusions.","authors":"Philipp Breitbart, Dirk Westermann, Grigorios Korosoglou","doi":"10.21037/cdt-24-423","DOIUrl":"10.21037/cdt-24-423","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"14 6","pages":"1007-1010"},"PeriodicalIF":2.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular diagnosis and therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1